Franklin Resources
CRNX

Franklin Resources’s Crinetics Pharmaceuticals CRNX Stock Holding History

Franklin Resources’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$784K Buy
20,959
+2,224
+12% +$82.7K ﹤0.01% 2389
2026
Q1 		$680K Buy
18,735
+1,064
+6% +$47.5K ﹤0.01% 2349
2025
Q4 		$823K Sell
17,671
-2,729
-13% -$121K ﹤0.01% 2183
2025
Q3 		$850K Sell
20,400
-628,738
-97% -$20.1M ﹤0.01% 2193
2025
Q2 		$18.7M Sell
649,138
-314,143
-33% -$9.7M ﹤0.01% 949
2025
Q1 		$32.3M Sell
963,281
-628,385
-39% -$23.5M 0.01% 747
2024
Q4 		$81.4M Buy
1,591,666
+201,556
+14% +$11.3M 0.02% 467
2024
Q3 		$73.8M Buy
1,390,110
+528,688
+61% +$27.3M 0.02% 479
2024
Q2 		$38.6M Buy
861,422
+448,213
+108% +$20.7M 0.01% 635
2024
Q1 		$19.3M Hold
413,209
– – 0.01% 881
2023
Q4 		$14.7M Buy
413,209
+274,384
+198% +$8.41M 0.01% 839
2023
Q3 		$4.13M Buy
138,825
+34
+0% +$701 ﹤0.01% 1143
2023
Q2 		$2.5M Buy
138,791
+261
+0.2% +$5.21K ﹤0.01% 1332
2023
Q1 		$2.22M Buy
+138,530
New +$2.56M ﹤0.01% 1333

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's CRNX Position: Q2 2026 in Review

Franklin Resources increased its Crinetics Pharmaceuticals (CRNX) stake by 12% in Q2 2026, buying an estimated $82.7K and bringing the position to 20,959 shares worth $784K. The position accounts for ﹤0.01% of the portfolio, ranked #2389.

Franklin Resources first reported a position in CRNX in Q1 2023 and has held it in 14 quarters since. The position peaked at $81.4M in Q4 2024. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Franklin Resources held 20,959 shares of Crinetics Pharmaceuticals worth $784K as of Q2 2026.
  • Franklin Resources bought 2,224 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $82.7K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2389 holding.
  • Franklin Resources first reported a position in Crinetics Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Franklin Resources's Crinetics Pharmaceuticals position peaked at $81.4M in Q4 2024.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.